Clinical Therapeutics10.1016/j.clinthera.2017.11.007201840183-94Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled TrialChee Hae Kim, Kyung Ah Han, Jaemyung Yu, Sang Hak Lee, Hui Kyung Jeon, Sang Hyun Kim, Seok Yeon Kim, Ki Hoon Han, Kyungheon Won, Dong-Bin Kim, Kwang-Jae Lee, Kyungwan Min, Dong Won Byun, Sang-Wook Lim, Chul Woo Ahn, SeongHwan Kim, Young Joon Hong, Jidong Sung, Seung-Ho Hur, Soon Jun Hong, Hong-Seok Lim, Ie Byung Park, In Joo Kim, Hyoungwoo Lee, Hyo-Soo Kim,
Clinical Nutrition10.1016/j.clnu.2015.11.003201736179-84Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trialAlireza Soleimani, Mohsen Taghizadeh, Fereshteh Bahmani, Negin Badroj, Zatollah Asemi,
Journal of Clinical Lipidology10.1016/j.jacl.2013.01.006201373199-207Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) studyIchiro Tatsuno, Yasushi Saito, Kentarou Kudou, Jun Ootake,
Diabetes10.2337/db22-15-lb202271Supplement_115-LB: Safety and Efficacy of Tetramethylpyrazine Nitrone in Treating Patients with Type 2 Diabetes and Microalbuminuria—A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical TrialJINKUI YANG,
Clinical Neurology and Neurosurgery10.1016/j.clineuro.2021.1069542021210106954Neuroaspis PLP10™, a nutritional formula rich in omega-3 and omega-6 fatty acids with antioxidant vitamins including gamma-tocopherol in early Parkinson’s disease: A randomized, double-blind, placebo-controlled trialMarios Pantzaris, George Loukaides, Dimitrios Paraskevis, Evangelia-Georgia Kostaki, Ioannis Patrikios,
Clinical Nutrition ESPEN10.1016/j.clnesp.2021.09.073202146S565Supplemental parenteral nutrition enriched with omega-3 polyunsaturated fatty acids in intensive care patients – a randomized, controlled, double-blind clinical trialP. Singer, R. Mesalati-Stahzi, I. Bendavid, M. Theilla, A. Ariel, I. Kagan,
Diabetes & Metabolism Journal10.4093/dmj.2018.0265202044178Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialJi Eun Jun, In-Kyung Jeong, Jae Myung Yu, Sung Rae Kim, In Kye Lee, Kyung-Ah Han, Sung Hee Choi, Soo-Kyung Kim, Hyeong Kyu Park, Ji-Oh Mok, Yong-ho Lee, Hyuk-Sang Kwon, So Hun Kim, Ho-Cheol Kang, Sang Ah Lee, Chang Beom Lee, Kyung Mook Choi, Sung-Ho Her, Won Yong Shin, Mi-Seung Shin, Hyo-Suk Ahn, Seung Ho Kang, Jin-Man Cho, Sang-Ho Jo, Tae-Joon Cha, Seok Yeon Kim, Kyung Heon Won, Dong-Bin Kim, Jae Hyuk Lee, Moon-Kyu Lee,,
Biological Psychiatry10.1016/j.biopsych.2007.03.0282008632e13Regarding “Omega-3 Fatty Acids Supplementation in Children with Autism: A Double-Blind Randomized, Placebo-Controlled Pilot Study”Donald L. Gilbert,
Journal of Diabetes and its Complications10.1016/j.jdiacomp.2017.06.01020173191394-1400Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trialZahra Soleimani, Fatemeh Hashemdokht, Fereshteh Bahmani, Mohsen Taghizadeh, Mohammad Reza Memarzadeh, Zatollah Asemi,
Clinical Nutrition10.1016/j.clnu.2014.06.0052015343388-393Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trialMansooreh Samimi, Mehri Jamilian, Zatollah Asemi, Ahmad Esmaillzadeh,